Merck & Co., Inc. (MRK) › Cost of RevenueMerck & Co., Inc. (MRK) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $14.03B2017: $12.91B2018: $13.51B2019: $12.02B2020: $13.62B2021: $13.63B2022: $17.41B2023: $16.13B2024: $15.19B2025: $16.38B$16.38B2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$16.38B+7.8%2024$15.19B-5.8%2023$16.13B-7.4%2022$17.41B+27.8%2021$13.63B+0.1%2020$13.62B+13.3%2019$12.02B-11.1%2018$13.51B+4.6%2017$12.91B-8.0%2016$14.03B—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share